Ruxolitinib
Uses
Jakavi, Ruxolitinib is used in the treatment of chronic idiopathic myelofibrosis and polycythemia vera.
How it Works
Jakavi, Ruxolitinib treats bone marrow disorders that affect the body's ability to produce blood cells. Jakavi, Ruxolitinib works by blocking certain enzymes in the body that affect blood cell production. Jakavi, Ruxolitinib works by blocking the signal that triggers production of abnormal cancer cells and thus stops the production of these cancer cells.
Common Side effects
Some of the potential side effects of Jakavi, Ruxolitinib include the symptoms below;
Headache,
Reduced blood platelets,
Bruising,
Dizziness,
Anemia
Popular Products
Similar Product
